Författare: mkmedia

ISAB’s new nebulizer feature delivers the stability, precision and control of a dry powder aerosol—from a liquid solution. Developed by popular demand, four nebulizer modules have already been…

From Austria to Sweden to California to the UK: October has been an intensive month for PreciseInhale®, ISAB’s flagship product. It has been spotlighted by senior ISAB clients…

“Pathaway speak our language. Their network and expertise within the UK’s IVD (in vitro diagnostic) market is outstanding”, on June 5 ISAB CEO Lena Heffler met with representatives…

Fraunhofer ITEM (Institute for Toxicology and Experimental Medicine) is one of the world’s leading toxicology research organizations. At the SOT (Society of Toxicology) 2019 Conference in Baltimore it…

From cystic fibrosis to antibiotics, work on new inhalable biologic therapies is growing. With biologics formulated as liquid solutions, the need for precisely controllable wet, as well as…

Fraunhofer ITEM’s regular ‘Models of Lung Disease’ seminars are an influential meeting place for industry and academia to share knowledge on predictive lung disease models and translational lung…

Use of PBPK modelling to evaluate the performance of DissolvIt ®, a biorelevant dissolution assay for orally inhaled drug products. Mireille Hassoun, Maria Malmlof, Otto Scheibelhofer, Abhinav Kumar, Sukhi Bansal, Ewa Selg, Mattias Nowenwik, Per Gerde, Snezana…

Inhalation Sciences’ recent announcement of a 2 MSEK order from a leading inhalation company is the third major order announced since the appointment of Lena Heffler as new…

More industrial processes than ever are using nanoparticles. Yet many questions remain about the health consequences of inhaling them. Not just in our lungs but at a cellular,…

With a major 2.4 MSEKsale, a new European patent and the upcoming installation of ISAB’s first PreciseInhale® system in China – September and October 2018 have been eventful and…